Dergiler / Turkish Journal of Hematology / 2000 / Cilt: 17 - Sayı: 3

Multiple cerebral emboli in a homozygous $beta$-thalassaemia patient due to factor V 1299 (His-Arg) 4070 A-G mutation

Sayfa
133–136
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

We report a patient with cerebral thromboembolic episode triggered by a minor blood group incompatibility in which the underlying defect of factor V 1299 (His-Arg) was detected three years after his death.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Thromboembolic episodes are quite rare in beta thalassemia major patients although there is a tendency for thrombosis in haemolytic anaemias.
📊
Temel Bulgular & Veri:Thromboembolic episodes are quite rare in beta thalassemia major patients although there is a tendency for thrombosis in haemolytic anaemias.
💡
Sonuç & Katkı:We report a patient with cerebral thromboembolic episode triggered by a minor blood group incompatibility in which the underlying defect of factor V 1299 (His-Arg) was detected three years after his death.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Thromboembolic episodes are quite rare in beta thalassemia major patients although there is a tendency for thrombosis in haemolytic anaemias. We report a patient with cerebral thromboembolic episode triggered by a minor blood group incompatibility in which the underlying defect of factor V 1299 (His-Arg) was detected three years after his death.

🔖

Bu Makaleye Atıf Yap

AKAR, N., CİN, Ş., DEDA, G., KEMAHLI, S., UYSAL, Z., YILMAZ, E., AKAR, E. (2022). Multiple cerebral emboli in a homozygous $beta$-thalassaemia patient due to factor V 1299 (His-Arg) 4070 A-G mutation. Turkish Journal of Hematology, Cilt: 17 - Sayı: 3, 133–136. https://ajindex.com/articles/607138

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Constantopoulos A, Matsaniotis N. Hypertension, convulsions and cerebral haemorrhage in thalassemic patients after multiple blood transfusions. Helvetica Paediatrica Acta 1980;35:269-71
  2. Jensen H, Menis V, Guarin L, Baffa MC, Piomelli S. Protein C and protein S deficiencies in chronically transfused patients with hemoglobinopathy. Thromb Haemost 1991;65:1206
  3. Logothetis J, Constanoulakis M, Economidou J, Stefanis C, Hakas P, Agoustaki O, Sofraniadou K, Loewenson B, Bilek M. Thalassemia major (homozygous betathalassemia). A survey fo 138 cases with emphasis on neurologic and muscular aspects. Neurology, 1972;22:294-304
  4. Musumeci S, Leonardi S, Di Rio R, Fischer A, Di Costa G. Protein C and antithrombin III in polytransfused thalassemic patients. Acta Haematol 1987; 77:30-3
  5. Sinniah D, Ekert H, Bosco J, Nathan L, Koe SL. Intracranial hemorrhage and circulating coagulation inhibitor in, b-thalassemia major. J Pediatr 1981;99: 700-3
  6. Sinniah D, Vignaendra V, Ahmad K. Neurological complications in, b-thalassemia major. Archives of Disease in Childhood 1977;52:977-9
  7. Wasi P, Na-Nakorn S, Pootrakul P, Sonakul D, Piankijagum A, Pachare P. A syndrome of hypertension, convulsion and cerebral hemorrhage in thalassemic patients after multeple blood transfusions. Lancet 1978;16:602-4
  8. Kemahlı S, Gürman C, Eğin Y, Yıldırmak Y, Sipahi T, Uysal Z, Akar N, Cin Þ, Arcasoy A. Hypercoagulability in Children With Thalassemia Major. Clin Appl Thrombosis/Hemostasis 1997;3(2):129-32
  9. Borgna Pigmatti C, Camelli V, Caruso V, Dore F, De Mattia D, Di Palma A, Di Gregorio F, Romeo MA, Longhi R, Mangiogli A, Melevendi C, Pizzarelli G, Musumeci S. Thromboembolic events in beta thalassemia major: An Italian multicenter study. Acta Haematol 1998;99:76-9
  10. Akar N, Kemahlı S, Uysal Z, Cin Ş. Thromboembolism in, ß-Thalassemia Major. Acta Haematol 1998; 100:166
  11. Bernardi F, Faioni EM, Castoldi E, Lunghi B, Castaman G, Sacchi E, Manucci PM. A factor V genetic component differing from Factor V R 506 Q contributes to the activated protein C resistance phenotype. Blood 1997;90:1552
  12. Castaman G, Lunghi B, Missiaghia E, Bernardi F, Rodeghiero F. Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg 506 Gln (Factor V Leiden) and His 1299 Arg substitutions in factor V. Br J Haematol 1997;99:257-61
  13. Lunghi B, Iacoviello L, Gemmati D, di Iasio MG, Castoldi E, Pinotti M, Castaman G, Redaelli R, Mariani G, Marchetti